Alan Dunton

Alan Dunton

Director/Miembro de la Junta en CORMEDIX INC. .

Fortuna: 595 501 $ al 31/05/2026

71 años
Health Technology
Consumer Services
Commercial Services

Perfil

Dr. Alan W.
Dunton
, MD, is an Independent Non-Executive Director at Recce Pharmaceuticals Ltd., an Independent Director at CorMedix, Inc., an Independent Director at Palatin Technologies, Inc. and an Independent Director at Oragenics, Inc. He is on the Board of Directors at Recce Pharmaceuticals Ltd., CorMedix, Inc., Cytogel Pharma LLC, Palatin Technologies, Inc., Oragenics, Inc. and ActivBiotics, Inc. Dr. Dunton was previously employed as an Independent Non-Executive Director by Regeneus Ltd., a SVP-Regulatory Affairs, Research & Development by Purdue Pharma LP, a Non-Executive Director by Bionomics Ltd., a Chief Medical Officer by Derma Sciences, Inc., a Non-Executive Chairman by EpiCept Corp., a Chief Medical Officer by Marina Biotech, Inc., a Managing Director by Panacos Pharmaceuticals, Inc., an Independent Director by Targacept, Inc., a Principal Owner by Danerius LLC, a President & Chief Executive Officer by Metaphore Pharmaceuticals, Inc., a President, Chief Operating Officer & Director by Emisphere Technologies, Inc., a President & Managing Director by The Janssen Research Foundation, a Senior Executive by Johnson & Johnson, a Vice President-Clinical Research & Development by Syntex Corp., a Vice President-Clinical Research & Development by Ciba-Geigy Corp., a Vice President-Clinical Research & Development by Hoffmann-La Roche, Inc., a Chairman by Janssen-Cilag International NV, He received his undergraduate degree from State University of New York at Buffalo and a doctorate degree from New York University School of Medicine.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
13/04/2026 40.250 ( 0,05 % ) 339 710 $ 31/05/2026
09/12/2025 14.081 ( 0,79 % ) 197 416 $ 31/05/2026
30/06/2025 146.288 ( 0,05 % ) 57 889 $ 31/05/2026
30/04/2026 802 ( 0,02 % ) 486 $ 31/05/2026

Cargos activos de Alan Dunton

EmpresasCargoInicio
CORMEDIX INC. Director/Miembro de la Junta 01/03/2019
ORAGENICS, INC. Director/Miembro de la Junta 01/04/2011
PALATIN TECHNOLOGIES, INC. Director/Miembro de la Junta 22/06/2011
RECCE PHARMACEUTICALS LTD Director/Miembro de la Junta 14/07/2020
Director/Miembro de la Junta 01/10/2018
Director/Miembro de la Junta 01/01/2007

Antiguos cargos conocidos de Alan Dunton.

EmpresasCargoFin
REGENEUS LTD Director/Miembro de la Junta 25/02/2021
Director Técnico/Científico/I+D 01/03/2018
ADHERA THERAPEUTICS, INC. Director Técnico/Científico/I+D 21/02/2017
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Alan Dunton.

Formación de Alan Dunton.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

72

Relaciones de 1er grado

34

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

The Janssen Research Foundation

R.W. Johnson Pharmaceutical Research Institute

Danerius LLC

Commercial Services

Johnson & Johnson Pharmaceutical Group

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

ÚLTIMAS HORA | -40%. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN